We are live on ! Find out more
CTSO icon

Cytosorbents Corp

38 hedge funds and large institutions have $8.69M invested in Cytosorbents Corp in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 36 → 38 (+2)

5% more capital inflows, than outflows

Capital inflows: $1.01M | Capital outflows: $956K

0.1% more ownership

Funds ownership: 6.16% → 6.26% (+0.1%)

39% less call options, than puts

Call options by funds: $95K | Put options by funds: $157K

Holders
38
Holders Change
+2
Holders Change %
+5.56%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
8
Closed
6
Calls
$95K
Puts
$157K
Net Calls
-$62K
Net Calls Change
-$331K

CTSO Hedge Fund Activity: Q4 2016 in Review

38 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2016, worth a combined $8.69M — down 13% from $10M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 8 trimmed.

The largest buyer was Manatuck Hill Partners, opening a new position worth an estimated $274K. The largest seller was Douglass Winthrop Advisors, exiting entirely with an estimated $451K sold.

  • 38 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2016, up from 36 in Q3 2016.
  • Funds reported $8.69M of Cytosorbents Corp stock for Q4 2016, down 13% quarter-over-quarter.
  • 8 funds opened new Cytosorbents Corp positions in Q4 2016 and 6 closed out, a net change of +2 holders.
  • The largest Cytosorbents Corp buyer in Q4 2016 was Manatuck Hill Partners, an estimated $274K added.
  • The largest Cytosorbents Corp seller in Q4 2016 was Douglass Winthrop Advisors, an estimated $451K sold.

Based on aggregated 13F filings for Q4 2016.